Ingallina; Cinzia
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ingallina; Cinzia.The latest application filed is for "notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia".
- Ingallina; Cinzia - Latina IT
- INGALLINA; Cinzia - Roma IT
- Ingallina; Cinzia - Rome IT
- INGALLINA; Cinzia - Roma RM
| Patent | Date |
|---|---|
| Notch Inhibitors For Use In The Treatment Of T-cell Acute Lymphoblastic Leukemia App 20210363121 - Botta; Bruno ; et al. | 2021-11-25 |
| Notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia Grant 11,104,657 - Botta , et al. August 31, 2 | 2021-08-31 |
| Compounds For Use In The Treatment Of Brain Diseases App 20210030714 - LIMATOLA; Cristina ; et al. | 2021-02-04 |
| Notch Inhibitors For Use In The Treatment Of T-cell Acute Lymphoblastic Leukemia App 20190337916 - Botta; Bruno ; et al. | 2019-11-07 |
| Multitarget hedgehog pathway inhibitors and uses thereof Grant 10,093,642 - Botta , et al. October 9, 2 | 2018-10-09 |
| Multitarget Hedgehog Pathway Inhibitors And Uses Thereof App 20160368886 - BOTTA; Bruno ; et al. | 2016-12-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 